These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13679018)

  • 1. Justification of glioma biology beyond a cellular basis of interpretation.
    Agius LM
    Med Hypotheses; 2003 Oct; 61(4):486-94. PubMed ID: 13679018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Transition as a Survival Strategy of Glioma.
    Ichikawa T; Otani Y; Kurozumi K; Date I
    Neurol Med Chir (Tokyo); 2016 Jul; 56(7):387-95. PubMed ID: 27169497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliomatous transformation and demyelinating diseases.
    Anderson M; Hughes B; Jefferson M; Smith WT; Waterhouse JA
    Brain; 1980 Sep; 103(3):603-22. PubMed ID: 7417780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origins of glioma: E Pluribus Unum?
    Siebzehnrubl FA; Reynolds BA; Vescovi A; Steindler DA; Deleyrolle LP
    Glia; 2011 Aug; 59(8):1135-47. PubMed ID: 21351156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF beta signaling and its role in glioma pathogenesis.
    Kaminska B; Kocyk M; Kijewska M
    Adv Exp Med Biol; 2013; 986():171-87. PubMed ID: 22879069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of Gliomas.
    Cahill D; Turcan S
    Semin Neurol; 2018 Feb; 38(1):5-10. PubMed ID: 29548046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of glioma cyst formation.
    Adn M; Saikali S; Guegan Y; Hamlat A
    Med Hypotheses; 2006; 66(4):801-4. PubMed ID: 16321475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of our understanding on glioma.
    Martin-Villalba A; Okuducu AF; von Deimling A
    Brain Pathol; 2008 Jul; 18(3):455-63. PubMed ID: 18371180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrence of multiple sclerosis and glioma.
    Currie S; Urich H
    J Neurol Neurosurg Psychiatry; 1974 May; 37(5):598-605. PubMed ID: 4365433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
    Kristt DA; Yarden Y
    Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pathophysiology of Post-Traumatic Glioma.
    Simińska D; Kojder K; Jeżewski D; Kojder I; Skórka M; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know.
    Delgado-López PD; Saiz-López P; Gargini R; Sola-Vendrell E; Tejada S
    Clin Transl Oncol; 2020 Nov; 22(11):1909-1922. PubMed ID: 32222898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of neural stem cells with their vascular niche: implications in the malignant progression of gliomas.
    Barami K
    J Clin Neurosci; 2008 Nov; 15(11):1193-7. PubMed ID: 18617407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma after cerebral hydatid disease.
    St George EJ; Hillier CE; Hatfield R
    Childs Nerv Syst; 2003 Dec; 19(12):837-40. PubMed ID: 14566419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The etiopathogenesis of diffuse low-grade gliomas.
    Darlix A; Gozé C; Rigau V; Bauchet L; Taillandier L; Duffau H
    Crit Rev Oncol Hematol; 2017 Jan; 109():51-62. PubMed ID: 28010898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells and neuro-oncology: quo vadis?
    Recht L; Jang T; Savarese T; Litofsky NS
    J Cell Biochem; 2003 Jan; 88(1):11-9. PubMed ID: 12461769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
    Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
    Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma infiltration and extracellular matrix: key players and modulators.
    Ferrer VP; Moura Neto V; Mentlein R
    Glia; 2018 Aug; 66(8):1542-1565. PubMed ID: 29464861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins.
    Rutka JT; Giblin JR; Apodaca G; DeArmond SJ; Stern R; Rosenblum ML
    Cancer Res; 1987 Jul; 47(13):3515-22. PubMed ID: 3555773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.